Drugs / H7N9c
last change Sep 2014 re-read 3 minutes ago

H7N9c

Vaccine

Developed for
avian influenza
Investigated by
Novartis Vaccines

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01928472 Aug 2013 → Sep 2014 avian influenza Novartis Vaccines Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as H7N9c ClinicalTrials.gov intervention name — accepted as the source's own label NCT01928472 ↗
Known as A/H7N9 Monovalent Subunit Influenza Virus Vaccine “A/H7N9 Monovalent Subunit Influenza Virus Vaccine (H7N9c)” NCT01928472 ↗
Modality Vaccine “Monovalent Subunit Influenza Virus Vaccine” NCT01928472 ↗